| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SIENTRA INC | 2,730,765 | 68,897,000 | 30.30% | ||
| 2 | NANOSTRING TECHNOLOGIES INC | 3,959,440 | 61,055,000 | 26.85% | ||
| 3 | Catabasis Pharmaceuticals Inc | 2,752,488 | 33,608,000 | 14.78% | ||
| 4 | Oxford Immunotec Global PLC | 2,167,377 | 30,018,000 | 13.20% | ||
| 5 | VBI Vaccines Inc. | 4,971,091 | 13,323,000 | 5.86% | ||
| 6 | TETRALOGIC PHARMA CO | 4,644,705 | 10,867,000 | 4.78% | ||
| 7 | Neothetics Inc | 1,071,429 | 9,643,000 | 4.24% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-15-000565, filed 2015.07.30).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
